How these changes in GlyRs affect pain perception per se or contribute to the development of cognitive deficits, anxiety disorders, and depression commonly associated with chronic pain and involve the amygdala are exciting questions that arise from the present study. This evidence concerns the gene GARS1 and depressive symptom measurement.